CDC25B dephosphorylates and activates Cyclin-dependent Kinase 1/Cyclin B (CDK1/Cyclin B), which have been shown to be overexpressed in breast cancer and promote cell cycle progression (Cairns et al., 2020; Guo et al., 2022). Here, CDC25B is linked to breast carcinoma.